Guangdong Lifestrong Pharmacy Co., Ltd. (SHE:301111)
18.46
+0.03 (0.16%)
Oct 23, 2026, 3:04 PM CST
SHE:301111 Revenue
Guangdong Lifestrong Pharmacy had revenue of 78.58M CNY in the quarter ending June 30, 2026, a decrease of -6.41%. This brings the company's total for the last twelve months to 304.63M, up 8.39% year-over-year. In the year 2025, Guangdong Lifestrong Pharmacy had annual revenue of 314.64M with 12.92% growth. That makes Guangdong Lifestrong Pharmacy the 28,581st largest company in the world by revenue and 4,868th in China.
Revenue (ttm)
304.63M
Revenue Growth
+8.39%
P/S Ratio
9.70
Revenue / Employee
527.03K
Employees
578
Market Cap
2.95B
Revenue by Segment
- Drug 271.91M 86.4%
- Medical Services and Health Management 24.50M 7.8%
- Health Consumer Products 16.70M 5.3%
- Others 1.52M 0.5%
Fiscal year ended Dec 31, 2025 See the full SHE:301111 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 314.64M | 36.00M | 12.92% |
| Dec 31, 2024 | 278.64M | -13.76M | -4.71% |
| Dec 31, 2023 | 292.40M | 9.06M | 3.20% |
| Jan 1, 2023 | 283.34M | -66.45M | -19.00% |
| Jan 1, 2022 | 349.79M | 8.83M | 2.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Zhuhai Rundu Pharmaceutical | 1.34B |
| Anhui Sunhere Pharmaceutical Excipients | 993.60M |
| Zhejiang Cheng Yi Pharmaceutical | 827.47M |
| Baotou Dongbao Bio-Tech Co.,Ltd | 790.94M |
| Jiangxi Synergy Pharmaceutical | 784.40M |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 737.90M |
| Tibet AIM Pharm. | 684.45M |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 491.90M |